Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future

The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications

(2016) David E. Kandzari et al.   AMERICAN HEART JOURNAL

Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients

(2016) Jan Filipovský et al.   BLOOD PRESSURE

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

(2016) Alexander A. Leung et al.   CANADIAN JOURNAL OF CARDIOLOGY

Global Disparities of Hypertension Prevalence and ControlClinical Perspective

(2016) Katherine T. Mills et al.   CIRCULATION

New Approaches to Evaluating and Monitoring Blood Pressure

(2016) Elizabeth M. Goldberg et al.   CURRENT HYPERTENSION REPORTS

Device-based Therapy for Hypertension

(2016) Fu L. Ng et al.   CURRENT HYPERTENSION REPORTS

Interventional procedures and future drug therapy for hypertension

(2016) Melvin D. Lobo et al.   EUROPEAN HEART JOURNAL

Renal Nerve Stimulation–Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal DenervationNovelty and Significance

(2016) Mark R. de Jong et al.   HYPERTENSION

Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial

(2016) Sverre E. Kjeldsen et al.   HYPERTENSION

Effects of blood pressure lowering treatment in hypertension

(2016) Costas Thomopoulos et al.   JOURNAL OF HYPERTENSION

Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model

(2016) Felix Mahfoud et al.   JOURNAL OF HYPERTENSION

Effects of blood pressure lowering on outcome incidence in hypertension

(2016) Costas Thomopoulos et al.   JOURNAL OF HYPERTENSION

Regression to the Mean in SYMPLICITY HTN-3

(2016) Stuart J. Pocock et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension

(2016) Christian Ott et al.   Journal of the American Heart Association

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

(2015) Sverre E. Kjeldsen et al.   BLOOD PRESSURE

Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis

(2015) Sebastian Ewen et al.   Clinical Research in Cardiology

Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design: Figure 1

(2015) Felix Mahfoud et al.   EUROPEAN HEART JOURNAL

The double challenge of resistant hypertension and chronic kidney disease

(2015) Patrick Rossignol et al.   LANCET

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial

(2015) Michel Azizi et al.   LANCET

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension

(2015) Abraham R. Tzafriri et al.   Science Translational Medicine

Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation

(2015) Klaus Tiroch et al.   EuroIntervention

Renal Denervation for the Treatment of Cardiovascular High Risk-Hypertension or Beyond?

(2014) Michael Böhm et al.   CIRCULATION RESEARCH

Disproportional Decrease in Office Blood Pressure Compared With 24-Hour Ambulatory Blood Pressure With Antihypertensive Treatment

(2014) Roland E. Schmieder et al.   HYPERTENSION

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

(2014) Gianfranco Parati et al.   JOURNAL OF HYPERTENSION

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

(2014) Costas Thomopoulos et al.   JOURNAL OF HYPERTENSION

TCT-422 Transluminal Imaging of Renal Nerves using Optical Coherence Tomography

(2014) Fumiaki Ikeno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Baroreflex activation therapy safely reduces blood pressure for at least five years in a large resistant hypertension cohort

(2014) George Bakris et al.   Journal of the American Society of Hypertension

A Controlled Trial of Renal Denervation for Resistant Hypertension

(2014) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

(2013) Felix Mahfoud et al.   EUROPEAN HEART JOURNAL

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

Blood pressure changes after renal denervation at 10 European expert centers

(2013) A Persu et al.   JOURNAL OF HUMAN HYPERTENSION

Resistant hypertension? Assessment of adherence by toxicological urine analysis

(2013) Oliver Jung et al.   JOURNAL OF HYPERTENSION

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

(2013)   LANCET

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

(2013) Henry Krum et al.   LANCET

Lay perspectives on hypertension and drug adherence: systematic review of qualitative research

(2012) I. J. Marshall et al.   BMJ-British Medical Journal

Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

(2011) John D. Bisognano et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE